Prosecution Insights
Prosecution Insights
2 pending office actions • 0 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Contipro A S is currently navigating 2 pending office actions. These actions are assigned to 2 distinct examiners, meaning the company's active cases are split between different individuals. The data indicates 0 distinct art units for these filings, placing the emphasis on the individual examiner interactions. Managing 2 distinct examiners requires a strategy that can accommodate different communication styles and technical interpretations within the patent office.
The busiest examiner, LARA, CAROLINE MONSERRAT, is handling 1 busiest examiner pending action. This accounts for 1 of the active office actions currently facing the company. Practitioners should note that with 2 distinct examiners involved, the company must manage multiple sets of examiner preferences and timelines for its active matters. This distribution of the workload across multiple examiners suggests that the company is not currently facing a centralized bottleneck in its patent prosecution process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LARA, CAROLINE MONSERRAT | 1 | 100.0% | +0.0% |
| MCINTOSH III, TRAVISS C | 1 | 73.2% | +14.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18852078 | CRYOPRESERVATION MEDIUM COMPRISING HYALURONIC ACID, USE THEREOF AND METHOD OF CRYOPRESERVATION | LARA, CAROLINE MONSERRAT | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18719598 | HYALURONIC ACID DERIVATIVE HAVING A REDUCED POLARITY, METHOD OF PREPARATION THEREOF, COMPOSITION AND USE THEREOF | MCINTOSH III, TRAVISS C | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18852078 | CRYOPRESERVATION MEDIUM COMPRISING HYALURONIC ACID, USE THEREOF AND METHOD OF CRYOPRESERVATION | LARA, CAROLINE MONSERRAT | — | §103 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18719598 | HYALURONIC ACID DERIVATIVE HAVING A REDUCED POLARITY, METHOD OF PREPARATION THEREOF, COMPOSITION AND USE THEREOF | MCINTOSH III, TRAVISS C | — | §112 | Non-Final OA | — | Pending | Jun 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial